Description
Expanded GLP‑1 Signaling & Dual GH Pathway Support
This bundle is designed to stack seamlessly with Stage 1 once foundational compounds have been evaluated in isolation. Stage 2 introduces multi-receptor GLP‑1 coverage and a second GH stimulation pathway, allowing researchers to explore deeper appetite regulation, lipolytic signaling, and energy balance.
Included Peptides
- GLP‑1 R – 10mg
- Cagrilintide – 2.5mg
- Ipamorelin – 1omg
- Reconstitution Water – 10ml
Four-Receptor Concept
GLP‑1 R agonists typically engage three incretin-related receptors, supporting insulin modulation, gastric emptying, and appetite suppression. Cagrilintide, a synthetic amylin analog, targets the fourth receptor—the amylin receptor—activating satiety pathways not reached by GLP‑1 agonists alone. Together, they form a non-overlapping, four-receptor model for comprehensive metabolic signaling.
Optimization Logic
- Adds a second GLP‑1 R vial to complement Stage 1
- Introduces Cagrilintide for amylin receptor activation
- Adds Ipamorelin for GH stimulation via ghrelin receptor
- Designed for stacking with Stage 1 to build progressive metabolic momentum
All compounds are provided strictly for laboratory research and analytical reference. No claims are made regarding human outcomes. Researchers are encouraged to document each stage independently and consult available reference guides for reconstitution and storage.

Reviews
There are no reviews yet.